Search research articles
Contact Us
Filters
Showing results (71-80 of 162) with videos related to
Page
of 17
Sort By:
Blood Advances
|
November 15, 2024
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma
Lucia Y Chen, Santiago Thibaud, Saoirse Bodnar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2012
Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphoma
Adam M Petrich, Violetta Leshchenko, Pei-Yu Kuo, et al.
Science Translational Medicine
|
June 26, 2015
Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia
Zainul S Hasanali, Bikramajit Singh Saroya, August Stuart, et al.
Blood
|
June 5, 2007
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms
Samir Parekh, Jose M Polo, Rita Shaknovich, et al.
Blood
|
July 21, 2011
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
Matko Kalac, Luigi Scotto, Enrica Marchi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 13, 2023
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop
Evangelos Terpos, Paola Neri, Niels W C J van de Donk, et al.
Haematologica
|
April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab
Guido Lancman, Dahniel Sastow, Minira Aslanova, et al.
Blood
|
April 5, 2018
SOX11 augments BCR signaling to drive MCL-like tumor development
Pei-Yu Kuo, Shashidhar S Jatiani, Adeeb H Rahman, et al.
Journal for Immunotherapy of Cancer
|
April 12, 2024
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
David G Coffey, Keren Osman, Adolfo Aleman, et al.
Journal of Hematology & Oncology
|
May 9, 2023
Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
Muhammad Elnaggar, Sarita Agte, Paula Restrepo, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 162) with videos related to
Sort By:
Page
of 17
Blood Advances
|
November 15, 2024
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma
Lucia Y Chen, Santiago Thibaud, Saoirse Bodnar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2012
Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphoma
Adam M Petrich, Violetta Leshchenko, Pei-Yu Kuo, et al.
Science Translational Medicine
|
June 26, 2015
Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia
Zainul S Hasanali, Bikramajit Singh Saroya, August Stuart, et al.
Blood
|
June 5, 2007
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms
Samir Parekh, Jose M Polo, Rita Shaknovich, et al.
Blood
|
July 21, 2011
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
Matko Kalac, Luigi Scotto, Enrica Marchi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 13, 2023
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop
Evangelos Terpos, Paola Neri, Niels W C J van de Donk, et al.
Haematologica
|
April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab
Guido Lancman, Dahniel Sastow, Minira Aslanova, et al.
Blood
|
April 5, 2018
SOX11 augments BCR signaling to drive MCL-like tumor development
Pei-Yu Kuo, Shashidhar S Jatiani, Adeeb H Rahman, et al.
Journal for Immunotherapy of Cancer
|
April 12, 2024
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
David G Coffey, Keren Osman, Adolfo Aleman, et al.
Journal of Hematology & Oncology
|
May 9, 2023
Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
Muhammad Elnaggar, Sarita Agte, Paula Restrepo, et al.
Page
of 17